Ion mobility time-of-flight measurements: isolating the mobility of charge carriers during an epoxy–amine reaction

Polymer ◽  
2004 ◽  
Vol 45 (26) ◽  
pp. 8825-8835 ◽  
Author(s):  
Z. Guo ◽  
J. Warner ◽  
P. Christy ◽  
D.E. Kranbuehl ◽  
G. Boiteux ◽  
...  
Polymer ◽  
2003 ◽  
Vol 44 (12) ◽  
pp. 3537-3544 ◽  
Author(s):  
J. Warner ◽  
J. Guo ◽  
M. Khoshbin ◽  
S. Raheem ◽  
D.E. Kranbuehl ◽  
...  

2000 ◽  
Vol 15 (11) ◽  
pp. 2494-2498 ◽  
Author(s):  
Yang Yuan ◽  
Brian A. Gregg ◽  
Marcus F. Lawrence

Time-of-flight measurements performed on micron-thick films of liquid-crystalline zinc octakis(β-octoxyethyl) porphyrin indicated that charge carriers possess significantly high drift mobilities, attaining approximately 0.01 cm2 V−1s −1 and 0.008 cm2 V−1s −1 for holes and electrons, respectively, at room temperature. Upon heating the samples from 300 to 420 K, causing the porphyrin to go from the solid-crystalline to the discotic mesophase, the mobilities did not decrease drastically, and remained at values slightly larger than half those observed at room temperature. Charge transport in this material conformed to the Scher–Montroll model, which attributes a distribution of hopping times to the propagation of the initially formed charged carrier packet. Analysis of the “universal” plots prescribed by this model yielded a dispersion factor of 0.5 for both charge carriers.


2001 ◽  
Vol 8 (3) ◽  
pp. 572-576 ◽  
Author(s):  
K. Friedrich ◽  
J. Ulanski ◽  
G. Boiteux ◽  
G. Seytre

2020 ◽  
Vol 21 (11) ◽  
pp. 1016-1027 ◽  
Author(s):  
Fatemeh Emadi ◽  
Arash Emadi ◽  
Ahmad Gholami

Graphene Derivatives (GDs) have captured the interest and imagination of pharmaceutical scientists. This review exclusively provides pharmacokinetics and pharmacodynamics information with a particular focus on biopharmaceuticals. GDs can be used as multipurpose pharmaceutical delivery systems due to their ultra-high surface area, flexibility, and fast mobility of charge carriers. Improved effects, targeted delivery to tissues, controlled release profiles, visualization of biodistribution and clearance, and overcoming drug resistance are examples of the benefits of GDs. This review focuses on the application of GDs for the delivery of biopharmaceuticals. Also, the pharmacokinetic properties and the advantage of using GDs in pharmaceutics will be reviewed to achieve a comprehensive understanding about the GDs in pharmaceutical sciences.


2005 ◽  
Vol 243 (2) ◽  
pp. 382-386 ◽  
Author(s):  
P. Prins ◽  
F. C. Grozema ◽  
J. M. Schins ◽  
L. D. A. Siebbeles

1980 ◽  
Vol 169 (1) ◽  
pp. 185-198 ◽  
Author(s):  
S. Cierjacks ◽  
F. Hinterberger ◽  
G. Schmalz ◽  
D. Erbe ◽  
P.v. Rossen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document